The FDA has approved Journavx, a pain medication, offering a safer alternative to opioids. Learn about its benefits and side ...

The U.S. Food and Drug Administration (FDA) has approved Journavx, a new pain reliever without the risks of addiction or ...

The medication offers relatively modest pain relief, underscoring the challenges of finding new ways to manage pain.

People with acid reflux often rely on acid-reducing medications to ease symptoms. Depending on the severity of your symptoms, over-the-counter (OTC) and prescription options are available.

The drug represents a new pathway to treating people with pain due to surgeries or traumatic injuries, avoiding the addictive ...

The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class ...

The Spanish Association with Osteoporosis and Osteoarthritis (AECOSAR) and the Osteoarthritis Foundation International (OAFI) ...

Levetiracetam in sodium chloride injection is an antiepileptic drug indicated for adjunctive therapy in the treatment of partial-onset seizures in adults with epilepsy, myoclonic seizures in adults ...

Blockbuster diabetes drug Ozempic is on the list. That means the federal government and the pharmaceuticals industry are about to go head-to-head once again. The Centers for Medicare and Medicaid ...

had until Feb. 1 to release the list, but officials said the agency had routinely been ahead of schedule throughout the process. Coupled with the first 10 drugs that have already been negotiated ...

Ozempic, Rybelsus and Wegovy top the list of the newest drugs selected for Medicare Part D price negotiation, part of the Inflation Reduction Act. CMS this morning announced the selection of 15 ...

The Food and Drug Administration has said it is banning the use of Red No. 3, a synthetic dye that has long been used in the ...